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Abstract 
 
Background: Because economic data on the prophylactic usage of antibiotic in Iran are scant, we have con-
ducted a cross-sectional study with provider perspective to measure costs and appropriate use of antibiotics in 
surgical wards of 6 training hospitals affiliated to Shiraz University of Medical Sciences (SUMS), Iran. 
 
Methods: Over a six-month period 1,000 consecutive patients undergoing surgical operation were enrolled and 
information on prophylactic antibiotic administration was collected. The information included basic patient's de-
mographic data, types of surgery, category of antibiotic, dosage, dosage intervals, route of administration, num-
ber of doses, initiation times and duration of administration. In order to determine the agreement between pre-
scribed antibiotics and medical indication, the American Society of Health-System Pharmacists (ASHP) guide-
lines were applied. 
 
Results: Nine hundred and ninety three out of 1,000 patients (99.3%) had received at least one antibiotic and 
908 patients (91.4 %) received antibiotics because of a medical indication. Five out of 913 patients who had 
indications for antibiotic prophylaxis did not receive any antibiotic. Antibiotics were prescribed for 85 out of 87 
(98%) procedures in which an antibiotic was not indicated. The average cost of antibiotic prescription per surgical 
procedure was 786,936 Iranian Rials (corresponding to 99.60 USD or €82.90). The most frequent prescribed 
antibiotic was cefazoline adding 53.3% of the total cost of antibiotics. In total, 36,516,190 Iranian Rials (corre-
sponding to 4,622.95 USD or €3,845.20) were spent for cefazoline alone. 
 
Conclusion: The results of this study showed that all surgical patients received at least one antibiotic as prophy-
laxis for any infection in the surgical site. Our results indicate over- and misuse of antibiotics in Iran leading to a 
great amount of economic burden, since in 98% of all procedures, antibiotics were used inappropriately. 
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Introduction 
 
Without any doubt in course of infectious diseases, 
antibiotics can have an important role in global reduc-
tion of morbidity and mortality. However, if mis- or 
overused, they would result into an emergence for 
resistance to bacteria and lead to unnecessary costs.
1 
Bacterial resistance is associated with increased mor-
bidity and prolonged hospital stay, hence, contributes 
to a greater indirect costs. 
In several hospital settings in the US and Europe, 
antibiotics were shown as the second prescribed ther-
apeutic drugs. 60-90% of patients receive antibiotics, 
and in 40% of the cases, prescriptions are often with-
out any laboratory confirmation or have any indica-
tion for antibiotic use. It was shown that the rate of 
antibiotic misuse are higher in surgical departments 
than in internal medicine ones, and were mostly for 
prophylaxis than treatment.
2 
In developing countries, antibiotics are the largest 
single group of drugs purchased by patients. At the 
same time, in many developing countries, the availa-
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bility and use of antibiotics are poorly controlled and 
of course, it has been demonstrated that a restriction 
policy can be effective in decreasing the antibiotic use 
and increasing the rational prescription.
3 Misuse of an 
antibiotic is a multifactorial problem such as economic 
incentives, social norms that govern interactions be-
tween patients and physicians and between physicians 
too.
4 In recent years, the lack of governmental support 
to control the pharmaceutical industries has resulted in 
an increase in medication prices per capita in Iran. On 
the other hand, the average of therapeutics’ usage in 
Iran is 2 to 4 times higher than in Europe or the US. 
The most frequently prescribed drugs are acetamino-
phen and antibiotics for treatment of upper respiratory 
infections. 
There may be many explanations for this trend, in-
cluding the patients’ wrong attitude in using exces-
sive drugs and doctors’ tendency towards satisfaction 
of their patients though prescribing the requested 
medications.
5 On the other hand, some studies re-
vealed that the fear of increased costs should not limit 
the attempts to improve the appropriateness of an an-
tibiotic administration.
6 These factors may also lead 
to an improvement in antibiotics prescription, espe-
cially in hospital settings. 
Because of mis- and overuse of antibiotics to pre-
vent any infection in the surgical site in Shiraz, 
southern Iran
7-9 and also because of shortage of eco-
nomical data on expenses of the prophylactic use of 
antibiotics in Iran, this cross-sectional study was per-
formed to measure the costs and appropriate use of 
antibiotics in surgical wards of 6 teaching hospitals 
affiliated to Shiraz University of Medical Sciences 
(SUMS), Iran.  
 
 
Materials and Methods 
 
From February to July 2004 in surgical wards of 6 
teaching hospitals affiliated to Shiraz University of 
Medical Sciences, Iran, similar to previous studies,
7-9 
1,000 consecutive patients undergoing surgical opera-
tion were enrolled. Information on prophylactic antibi-
otic administration by referring to medical records and 
filling out data forms was collected. The collected in-
formation included hospital’s specifications, basic pa-
tient’s demographic data, type of surgery, and detailed 
antibiotic prescription (category of antibiotic, dosage, 
dosage intervals, route of administration, and number of 
doses, initiation times and duration of administration). 
In order to determine the agreement between pre-
scribed antibiotics and surgical treatment, the American 
Society of Health-System Pharmacists (ASHP) guide-
lines were applied.
10 The collected data was double-
checked by a medical expert in this field (infection 
control and pharmacology). By calculating direct 
costs of all antibiotics used and comparing the direct 
cost of ASHP guideline recommendation for each 
patient, the difference between real cost and recom-
mended cost was defined as extra cost. On July 31
st 
2004, 1 Iranian Rial corresponded to 0.0001266 USD 
or €0.0001053, respectively.
  
 
 
Results   
 
Among 1,000 consecutive surgical patients, 120 
(12.0%) were in departments of Cardiosurgery, 112 
(11.2%) in General/Gastrointestinal, 110 (11.0%) in 
Neurosurgery, 111 (11.1%) in Gynecology, 110 
(11.0%) in Ophthalmology, 115 (11.5%) in Or-
thopedy, 111 (11.1%) in ENT (Ear, Nose, Throat), 
and 110 (11.0%) in Urology Department. One-
hundred and one patients (10.1%) were transplanted 
patients, among them 23 (2.3% of all patients) were 
kidney, and 78 (7.8% of all patients) liver transplant-
ed ones.    
The patient’s age range was 86 years (1 to 87) 
(mean: 40±22). More than half of the patients were 
male (56%), and most of the procedures (91.4%) 
were elective. Almost all patients (993/1000; 99.3%) 
had at least one prescribed antibiotic, and 908 patients 
(91.4%) received antibiotics because of a medical 
indication. Five of 913 patients who had indications 
for antibiotic prophylaxis did not receive any antibi-
otic. However, an antibiotic was prescribed for 85 out 
of 87 (98%) procedures in which an antibiotic was 
not indicated (Figure 1). 
The costs of antibiotics used for various types of 
surgeries are shown in Diagram 1. The average cost 
of antibiotic prescription per surgical procedure 
was 786,936 Iranian Rials (corresponding to 99.60 
USD or €82.90). The most frequent prescribed an-
tibiotic was cefazoline (Table 1) which was used in 
67.4% of procedures and added 53.3% of the total 
cost of antibiotics. In total, 36,516,190 Iranian Ri-
als (corresponding to 4,622.95 USD or €3,845.20) 
were spent for cefazoline. In Table 1: Bring all cost 
as USD, B) Information of "the most and least us-
age by ward", does not give any valuable infor-
mation. Generally, the highest usage of antibiotics Hatam et al. 
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was found in Cardio-thoracic Surgery Ward ac-
counting for 27% of the total cost of antibiotics 
during the observation period. 
The quantity/ (DDD/strength)/ 1000 patients= 
number of DDDs per user per year which was as fol-
lows: Cefazolin=7.8175 g, Gentamicin=0.11 g, 
Amikacin=0.3477 g, Cephalexin=1.181 g, Ampicillin 
=0.06 g, Ceftriaxone=0.378 g, Cefixime=0.031 g, 
Chloramphenicol=0.15 g, Ciprofloxacin=0.311 g, 
Metronidazole=0.23 g, Amoxicillin=0.06 g, Cloxa-
cillin=0.01 g, Clindamycin=0.02 g, Erythromycin= 
0.004 g, Vancomycin=0.017 g and Penicillin 
G=97500 units. 
 
 
Discussion 
 
The results of this study showed that almost all sur-
gical patients received at least one antibiotic as 
prophylaxis for any infection in the surgical sites. 
Although this reflects the surgeons’ awareness of the 
value of antibiotics in prevention of surgical site in-
fections, our results also showed the overuse of anti-
biotics in Iran, since in 98% of all procedures anti-
biotics were used inappropriately. This finding is 
consistent with other studies conducted in average 
income countries.
11,12 
Bugnon-Reber and colleagues pointed out that the 
lack of indication is a popular reason for inappropri-
ate use of antibiotic.
1 It was also shown that the con-
sumption rate of antibiotics has been 31-35% in hos-
pitalised patients
2 and in our study, 8.6% of patients 
received antibiotics without any indication or justifi-
cation. However, the total adherence (appropriate-
ness of antimicrobial agent, initiation time of 
prophylaxis, duration of prophylaxis, route of 
prophylactic antibiotic administration) based on the 
ASHP guideline in 1,000 patients was 0.3%. Moss 
and colleagues
13 suggested the total rate for inappro-
priate use of antibiotics up to 47% and the reasons 
for this inappropriate use were economical factors or 
clinical errors. Al-Gamadi et al.
11 reported even 
higher rates of inappropriate usage of antibiotics for 
prophylactic reasons in the United Arab Emirates as 
80% of patients received antibiotics and in 72% of 
them, the usage was inappropriate. 
Overuse of antibiotics together with improper 
management may cause an increase in direct cost of 
treatment. Furthermore, overuse and inappropriate 
use of antibiotics lead to an increase in both bacteri-
al resistance and cost of treatment. Our findings 
showed that the rate of consuming an antibiotic costs 
4.75 times as much as that recommended by ASHP 
guideline. Because of inappropriate usage, the six 
hospitals under study paid an extra expense of 
54,054,210 Iranian Rials (corresponding to 6,843.26 
USD or €5,691.91) for surgical procedures among 
1,000 patients. 
Not Jus-
tified 
85 
(8.6%) 
Justified 
2 
(28.6%) 
Not Jus-
tified 
5 
(71.4%) 
Prophylaxis 
given 
993 
(99.3%) 
 
Prophylaxis 
not given 
7 
(0.7%) 
Reviewed 
1000 
(100.0 %) 
Prophylaxis 
Justified 
913 
(91.3%) 
Prophylaxis 
not justi-
fied 
87(8.7%) 
Given 
908 
(99.5%) 
Given 
85 
(97.7%) 
Not giv-
en 
2(2.3%) 
Fig. 1: Breakdown of procedures, according to justification and actual provision of prophylaxis. Economic burden of antibiotic use 
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A number of studies have focused on the issue of 
increasing cost of antibiotics based on inappropriate 
usage. Parret et al.
14 showed that by consulting spe-
cialists, the cost of antibiotics could decrease by 
3.5%. Wilkins and colleagues
15 demonstrated that by 
consulting specialists only 7% of patients received 
antibiotics for wrong indications. Furthermore, by 
consulting infectious disease specialists prior to pre-
scription of antibiotics, Moleski et al.
16 calculated 
financial savings between 16,000 to 60,000 USD. 
Hence, consultation and approval of antibiotic pre-
scription by infectious diseases consultants might be 
an effective option in significant reduction of costs. 
Also, specific antibiotic training programs showed to 
be effective in decreasing the frequency of inappro-
priate usage and costs.
17 
Fraser  et al. showed that application of specific 
guidelines for prescribing antibiotics can lead to an 
saving up to 400 USD per antibiotic prescription.
18 
Pestotnik and colleagues
19 assessed the use of com-
puter based medical expert software for appropriate 
antibiotic prescription and calculated a 23-25% reduc-
tion of costs. 
Our study has several limitations. As it is im-
portant to mention that there are different factors that 
affect on an appropriate prescription, including cul-
tural and educational factors, nurses and pharmacists 
influences, distribution and availability of medical 
compounds, and logical calculations. The influence of 
these factors was not examined in our study. In order 
to ensure cost-effective application of prophylactic 
antibiotics, Ristic´ et al. showed a significant change 
in prescribing patterns of antibiotic prophylaxis in 
caesarean sections following introduction of local 
guidelines. There was a significant decrease in use of 
‘third’ generation of cephalosporin’s whereas the use 
of ‘‘older’’ antimicrobial drugs with better safety and 
efficacy increased.
20 
Table 1: Antibiotics used and their costs in various types of surgeries 
 
Rank 
Antibiotic  Most of use  Least of use Total 
a 
price 
Percent of 
total cost 
(%) 
cost/ USD  Ward
b Cost/ USD Ward
b
  1  Cefazolin  1550  Cardiothoracic  29  Ophthalmology  4622  53.3  
  2  Amikacin  635  Cardiothoracic  1  General & Gas-
trointestinal 
700 8  
  3  Metronidazole  426.60  General & Gas-
trointestinal 
.70 Neurosurgery  533  6.1  
  4  Ceftriaxone  303.79  Transplantation  3.89  Orthopedics  762.9  8.8    
  5  Clindamycin  297  Orthopedics  30.07  ENT  384.7  4.4   
  6  Cefalexin  184.25  Orthopedics  24  General & Gas-
trointestinal 
611.4 7.05  
  7  Vancomycin  142  Neurosurgery  (only use in this ward)   142  1.6   
  8  Gentamycin  132.9  Orthopedics  0.68  Transplantation  480  5.5  
  9  Ciprofloxacin  71  Urology  0.50  Cardiothoracic  104  1.2  
10 Ampicillin  69.26  General  &  Gas-
trointestinal 
0.96 Neurosurgery  103.5  1.1  
11 Cefixime  64  Urology  1.55  Cardiothoracic  88  1  
12 Amoxicillin 44.2  ENT  10.36  General  &  Gas-
trointestinal 
54.5 0.6  
13 Chloramphen-
icol 
36.66 cardiology 22.13 Ophthalmology  588  6.7  
14 Penicillin  11.34  Orthopedics 2.48  General  &  Gas-
trointestinal 
13.8 0.1
15 Cloxacillin 8.08  Neurosurgery  0.66  General  &  Gas-
trointestinal 
8.75 0.1  
16 
 
erythromycin 1.15  General  &  Gas-
trointestinal 
0.27 Ophthalmology  2.47  0.0
 Total  cost  8666.25 
a MAX: Cefazolin  4622  MIN: Erythromycin  2.47  Ceftriaxone  764.23  Cloxacillin  8.75  Amikacin  700  Amoxicillin  
54.56 
b Most of antibiotic cost: Cardiothoracic Ward  2356.13, Least of antibiotic cost  : Ophthalmology Ward  159.85 Hatam et al. 
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Therefore, we think that it would be necessary to 
design an evidence based guideline according to local 
conditions and cultural background in order to im-
prove patient safety and decrease direct costs in the 
administration of antibiotic prophylaxis to prevent 
surgical site infection in Shiraz, Iran. 
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